ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,046Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 210

$767K Total Retail Price of All Prescriptions

Rank: 6 out of 210

1,089 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 9,480 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL SUCCINATE 776 630 1 5
CARVEDILOL 768 673 2 1
AMLODIPINE BESYLATE 493 438 3 4
CILOSTAZOL 470 424 4 41
LISINOPRIL 458 379 5 3
SIMVASTATIN 453 395 6 2
WARFARIN SODIUM 439 409 7 9
CLOPIDOGREL 395 333 8 10
PLAVIX 391 340 9 11
CRESTOR 341 292 10 14
BYSTOLIC 329 252 11 32
FUROSEMIDE 309 266 12 8
RAMIPRIL 299 278 13 27
DIOVAN 296 265 14 17
COREG CR 289 241 10 15 54
DIGOXIN 287 214 16 16
RANEXA 277 240 17 33
METOPROLOL TARTRATE 268 199 18 7
LOSARTAN POTASSIUM 253 211 19 13
ISOSORBIDE MONONITRATE ER 247 184 20 15
PRADAXA 205 189 21 22
ATORVASTATIN CALCIUM 164 145 22 6
AMIODARONE HCL 162 161 23 19
EFFIENT 156 148 24 37
SPIRONOLACTONE 134 109 25 24
HYDROCHLOROTHIAZIDE 117 84 26 18
DIOVAN HCT 111 85 27 26
NIASPAN 103 79 28 35
LOVAZA 88 69 29 43
POTASSIUM CHLORIDE 85 64 30 20
OMEPRAZOLE 83 55 31 31
ZETIA 76 68 32 23
BENAZEPRIL HCL 68 68 33 28
NITROSTAT 65 55 34 25
MULTAQ 65 65 34 49
LIPITOR 64 61 36 29
EXFORGE 55 54 37 65
NIFEDIPINE ER 50 50 38 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.